myPOS Welcomes New Chief Strategy Officer Jean Beaubois
European payment service provider myPOS is delighted to announce the appointment of new Chief Strategy Officer, Jean Beaubois, effective 11th of November 2019.
Jean Beaubois comes from SafeCharge, an international payment technology company, where he was in charge of Investor Relations and M&A for the last two years. Jean brings extensive experience and knowledge in payment technology, financial analysis and strategy - strengths gained at SafeCharge as well as leading investment banks such as Morgan Stanley and Goldman Sachs.
‘’Jean's appointment will contribute to myPOS’ financial strength and strategy‘’ - says Christo Georgiev, myPOS founder and CEO. “myPOS is growing exponentially, every month a record-high number of small companies are turning to myPOS to run their business with our all-in-one payment solution and Jean will help support our expansion strategy by looking for investments and partnerships”.
myPOS was created on the premise that every business, regardless of its size and the sector it operates in, needs to have access to innovative payments technology to sell its products or services to grow.
With that in mind, myPOS was the first and still is the only payment technology provider to deliver a free merchant account with immediate funds settlement at no extra cost. In addition to offering the best support to its clients, myPOS has developed its own sales channel of flagship stores opened sequentially in London, Amsterdam, Sofia, Milan, Barcelona, Antwerp and Paris, and is looking to open in Bucharest and Vienna next.
myPOS continues to introduce more competitive and innovative solutions to the European market such as the super affordable myPOS GO at just 29 EUR and the upcoming myPOS HUB+, the first countertop device for the company which combines a payment terminal, ECR and business management apps all in one.
About myPOS World Ltd
myPOS World Ltd is a fintech company operating the myPOS platform across Europe. The myPOS e-money accounts and payment services are provided by a myPOS-owned UK E-Money Institution, authorised and regulated by the FCA and by an associated EU-licensed E-Money Institution, a direct member of MasterCard, VISA, Amex, JCB, UnionPay and other card schemes.
myPOS headquarters is at Level 24, The Shard, London Bridge Street, London SE1 9SG, UK.
+44 20 3129 3086
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BearingPoint helps government and public sector organizations deliver critical health and public services during the Covid-19 pandemic6.7.2020 10:00:00 EEST | Press release
Management and technology consultancy BearingPoint announced today that it is helping its government and public sector clients across Europe to deliver critical health and public services during the Covid-19 pandemic through new delivery models, new ways of working, digitalization, and automation. “BearingPoint’s organization as a single, European-based business has meant we have been able to draw on capabilities, leading practices and learnings from across our government and public sector clients and teams in many different countries. Working remotely and in partnership with our clients, we have quickly mobilized resources to design and deliver solutions to support both the public services needed during Covid-19 and the new ways of working for public servants,” said Andrew Montgomery, Partner and Global Leader Government and Public Sector at BearingPoint. New delivery models and services People’s health and well-being during the Covid-19 crisis have required public services to rapidly
DNA Selects VisualOn’s OnStream® Android TV to Deliver the Highest Quality of Service for Their Over the Top (OTT) Deployment on the Android TV Platform6.7.2020 09:00:00 EEST | Press release
VisualOn, Inc., a streaming software provider that enables scalable, cross-platform media playback for leading video services, today announced that the company is now providing DNA's end users the ability to stream the highest quality video using the Android TV. DNA is Finland's largest cable operator. Launched in February this year, the new DNA TV has revamped DNA’s TV offering for IP-based delivery, introducing multiple features including unlimited NPVR recordings, a new user interface and improved video stream quality. Through its innovative program-centric approach, subscribers can view and record unlimited TV programs with unprecedented ease of use and watch live and VOD content whenever they want, anywhere in the EU via the DNA TV app. Furthermore, the service delivers compelling content recommendations based on users’ individual viewing preferences. VisualOn, powered by AWS, has closely supported DNA to build and deploy this platform. “Service reliability and a seamless user exp
EMA Validates and Grants Accelerated Assessment for Trastuzumab Deruxtecan for the Treatment of HER2 Positive Metastatic Breast Cancer6.7.2020 09:00:00 EEST | Press release
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for trastuzumab deruxtecan, a HER2 directed antibody drug conjugate (ADC), for the treatment of adults with unresectable or metastatic HER2 positive breast cancer who have received two or more prior anti-HER2 based regimens. Trastuzumab deruxtecan was granted accelerated assessment by the EMA’s Committee for Medicinal Products for Human Use (CHMP). Validation confirms that the application is complete and commences the scientific review process by the EMA’s CHMP. Accelerated assessment is granted by the CHMP to products expected to be of major interest for public health and therapeutic innovation and can significantly reduce the review timelines. “The accelerated assessment highlights the significant unmet need for patients with HER2 positive metastatic breast cancer that trastuzumab deruxtecan aims at addressing
Excelya Welcomes Three European Contract Research Organizations to Become One Stop Provider Throughout Europe6.7.2020 09:00:00 EEST | Press release
Today, Excelya, a leading contract research organization (CRO) specializing in clinical research, announced that three European CROs joined Excelya Group: Zeincro based in Central-Eastern & Southern Europe, The Clinical Company based in the Netherlands and Belgium and Koehler eClinical based in Germany. Together, they will be known as Excelya Group. This alliance will allow Excelya to offer a one stop provider service model throughout Europe for its clients, whether they need full service, functional service providing or consulting services. Zeincro is a leading contract research organization primarily operating in Central-Eastern & Southern Europe with particular expertise in clinical operations, safety and medical affairs. The Clinical Company is present in the Belgian and Dutch markets specializing in clinical operations. Koehler eClinical is a German specialty CRO with a focus on biostatistics and data solutions. Thanks to the unification with these three companies, Excelya Group i
Study Investigates Accuracy of Respiration Rate Obtained From Pulse Oximetry on Pediatric Patients Using Masimo RRp®6.7.2020 09:00:00 EEST | Press release
Masimo (NASDAQ: MASI) today announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp® on pediatric patients with the Rad-G™ Pulse Oximeter by comparing it to clinician-determined values while performing routine assessment of children admitted to outpatient and emergency departments.1 RRp provides respiration rate determined from the photoplethysmograph used in pulse oximetry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200705005031/en/ Masimo Rad-G™ with RRp® (Photo: Business Wire) Noting the high incidence of childhood pneumonia in many parts of the world, the inclusion of oxygen saturation (SpO2) and respiratory rate measurement in pneumonia screening guidelines, and the scarcity of medical equipment and variability in medical training in many low-resource settings, Dr. Alwadhi and colleagues sought to determine whether a “multi
Kepler Cheuvreux Initiates Coverage of Carbios6.7.2020 07:45:00 EEST | Press release
Regulatory News: CARBIOS (Euronext Growth Paris: ALCRB), a company pioneering new bio-industrial solutions to reinvent the lifecycle of plastic and textile polymers, today announces the publication of an initiation coverage report by Kepler Cheuvreux, a leading independent European financial services company specialized in research, execution and advisory services. Carbios is also covered by Bryan, Garnier & Co, Gilbert Dupont and Edison Investment Research. The research report entitled “zero-waste pioneer” released on June 23, 2020 by Kepler Cheuvreux is available on the website www.keplercheuvreux.com under “Research Public Access”. About Carbios: Carbios is a green chemistry company whose innovations help address the environmental and sustainable development challenges facing manufacturers. Since its creation in 2011 by Truffle Capital, the Company has developed, through biotechnology, two industrial processes that revolutionize the biodegradation and recycling of polymers. These in
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom